June 27, 2025

CGM Boosts Wound Healing, Lowers A1c: Study

Short-term CGM use improved A1c, wound healing, and reduced ED visits in diabetic foot patients, per data from ADA’s 85th Scientific Sessions.

Conexiant

June 26, 2025

Testosterone, Sleep Duration Linked to Psoriasis Risk

Low testosterone and insufficient sleep were both linked to higher odds of psoriasis in a U.S. population study, even after adjusting for age, BMI, and other factors.

Conexiant

June 25, 2025

Ultrasound Finds Early Insulin Resistance Signals

A handheld ultrasound probe could soon help detect metabolic issues long before blood sugar levels raise concerns.

Conexiant

June 25, 2025

Combo Obesity Therapy Preserves Muscle, Reduces Fat

A new combination therapy of semaglutide and bimagrumab helped patients lose more fat while preserving muscle mass, while a novel biosensor may help track muscle loss during obesity treatment.

Conexiant

June 24, 2025

HSV-1 Restructures Human Genome via Hijacking

Researchers uncovered how herpes simplex virus type 1 reprograms human chromatin structure by hijacking transcriptional machinery, potentially revealing a new antiviral target.

Conexiant

June 23, 2025

Older Adults Lead Vaccine Comeback

Older Americans are embracing vaccines—backed by new research confirming enhanced safety, disease prevention, and even a potential link to reduced dementia risk.

KFF Health News

June 20, 2025

Multiple Biological Drivers Identified in Hair Graying

New research identifies oxidative stress, DNA damage, genetic variants, and stem cell depletion as key drivers of hair graying, with emerging therapies under investigation.

Conexiant

June 19, 2025

Heavy Drinking Consistently Linked To Heart Risks

New research finds that heavy alcohol consumption consistently raises cardiovascular risks, while evidence for protective effects of light drinking remains inconclusive.

Conexiant

June 19, 2025

Single Psilocybin Dose Yields Long-Term Cancer Relief

A single psilocybin dose combined with therapy led to lasting reductions in depression and anxiety for cancer patients two years after treatment, according to new research.

Conexiant